title: Part 5: Unproven cell therapies and the commercialization of cell-based products.
authors.affiliation: Rubius Therapeutics, Cambridge, Massachusetts, USA. Past Chair, International Society for Cellular Therapy (ISCT) Commercialization Committee 2010-2014. Electronic address: rdeans@rubiustx.com.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Deans
authors.affiliation: Cell Medica Inc., Houston, Texas, USA. Immediate Past ISCT President, 2012-2014, and Chair, ISCT Advisory Board, 2014-2016.
authors.forename: Kurt C
authors.initials: KC
authors.lastname: Gunter
authors.affiliation: Division of Oncology, Laboratory of Cellular Therapy, University of Modena and Reggio Emilia, Modena, Italy. ISCT President 2014-2016, and Chair of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
authors.forename: Massimo
authors.initials: M
authors.lastname: Dominici
authors.affiliation: TxCell SA, Valbonne-Sophia Antipolis, France. Chair, ISCT Commercialization Committee 2014-2016.
authors.forename: Miguel
authors.initials: M
authors.lastname: Forte